Abstract
Clinical trials have established the benefits of implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) in the treatment of heart failure patients. As adjuncts to guideline-directed medical therapy, ICDs confer mortality benefits from sudden cardiac arrest, while CRT reduces mortality, hospitalisation rates and improves functional capacity. This review discusses the use of ICDs and CRT devices in heart failure management, outlining the evidence supporting their use, indications and contraindications.
Publication information
K Guha, A Morley Smith, HO Savage, T McDonagh, R Sharma. The effect of upgrade from dual chamber ICD to Cardiac Resynchronisation Therapy and Defibrillator upon arrhythmia burden. HFA 2013.